Schedule 13D ownership disclosure
LANDOS BIOPHARMA INC
Security class unavailable · CUSIP: 515069201
Event date: 2024-03-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-091996
- Form type
- SC 13D
- Filer
- Landos Biopharma, Inc.
- CIK
- CIK 1785345
- Filed
- Apr 10, 2024
- Reporting period
- Mar 24, 2024
- Description
- Schedule 13D beneficial ownership